TY - JOUR
T1 - Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice
T2 - Critical importance of timing of treatment
AU - Friedmann, A.
AU - Frankel, G.
AU - Lorch, Y.
AU - Steinman, L.
PY - 1987
Y1 - 1987
N2 - Susceptibility to demyelination caused by the WW isolate of Theiler's murine encephalomyelitis viruses is linked to class II genes of the major histocompatibility complex. SJL/J (H-2(s)) mice, expressing only I-A(s) class II gene products of the major histocompatibility complex, are highly susceptible to Theiler's murine encephalomyelitis virus infection with the WW virus isolate, with chronic paralysis and severe inflammation and demyelination in the central nervous system. The effect of in vivo administration of anti-I-A(s) monoclonal antibodies on Theiler's murine encephalomyelitis virus infection was observed. SJL/J mice were treated in various protocols pre- or postinfection. Anti-I-A(s) monoclonal antibody reversed chronic paralysis and reduced inflammation and demyelination when given after the establishment of persistent infection. The effect was long lasting, but clinical signs, inflammation, and demyelination recurred 2 months after treatment ceased. Anti-I-A(s) antibodies had no effect on viral titers within the central nervous system. The timing of the administration of monoclonal antibodies was critical. Administration of anti-I-A(s) before the establishment of the persistent infection resulted in fatal encephalitis.
AB - Susceptibility to demyelination caused by the WW isolate of Theiler's murine encephalomyelitis viruses is linked to class II genes of the major histocompatibility complex. SJL/J (H-2(s)) mice, expressing only I-A(s) class II gene products of the major histocompatibility complex, are highly susceptible to Theiler's murine encephalomyelitis virus infection with the WW virus isolate, with chronic paralysis and severe inflammation and demyelination in the central nervous system. The effect of in vivo administration of anti-I-A(s) monoclonal antibodies on Theiler's murine encephalomyelitis virus infection was observed. SJL/J mice were treated in various protocols pre- or postinfection. Anti-I-A(s) monoclonal antibody reversed chronic paralysis and reduced inflammation and demyelination when given after the establishment of persistent infection. The effect was long lasting, but clinical signs, inflammation, and demyelination recurred 2 months after treatment ceased. Anti-I-A(s) antibodies had no effect on viral titers within the central nervous system. The timing of the administration of monoclonal antibodies was critical. Administration of anti-I-A(s) before the establishment of the persistent infection resulted in fatal encephalitis.
UR - http://www.scopus.com/inward/record.url?scp=0023101299&partnerID=8YFLogxK
U2 - 10.1128/jvi.61.3.898-903.1987
DO - 10.1128/jvi.61.3.898-903.1987
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 3492612
AN - SCOPUS:0023101299
SN - 0022-538X
VL - 61
SP - 898
EP - 903
JO - Journal of Virology
JF - Journal of Virology
IS - 3
ER -